设为首页 加入收藏

TOP

STELARA (ustekinumab) injection, for subcutaneous (二十九)
2017-05-20 07:22:34 来源: 作者: 【 】 浏览:13710次 评论:0
th
ustekinumab (UNII: FU77B4U5Z0) (ustekinumab - UNII:FU77B4U5Z0) ustekinumab 130 mg  in 26 mL
INACTIVE INGREDIENTS
Ingredient Name Strength
Edetate Disodium (UNII: 7FLD91C86K) 0.52 mg  in 26 mL
Histidine (UNII: 4QD397987E) 20 mg  in 26 mL
Histidine Monohydrochloride Monohydrate (UNII: X573657P6P) 27 mg  in 26 mL
Methionine (UNII: AE28F7PNPL) 10.4 mg  in 26 mL
Polysorbate 80 (UNII: 6OZP39ZG8H) 10.4 mg  in 26 mL
Sucrose (UNII: C151H8M554) 2210 mg  in 26 mL
PRODUCT CHARACTERISTICS
Color YELLOW (colorless to slightly yellow) Score    
Shape  Size 
Flavor  Imprint Code 
Contains    
PACKAGING
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:57894-054-27 1 in 1 BOX 09/23/2016 
1  26 mL in 1 VIAL, SINGLE-USE; Type 0: Not a Combination Product  
2 NDC:57894-054-16 1 in 1 BOX 05/01/2017 
2  26 mL in 1 VIAL, SINGLE-USE; Type 0: Not a Combination Product  
MARKETING INFORMATION
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA761044 09/23/2016 
LABELER - JANSSEN BIOTECH, INC. (099091753)
ESTABLISHMENT
Name Address ID/FEI Business Operations
Patheon Biologics LLC  965750420 API MANUFACTURE(57894-060, 57894-061) , ANALYSIS(57894-060, 57894-061)
ESTABLISHMENT
Name Address ID/FEI Business Operations
Cilag AG  483237103 MANUFACTURE(57894-060, 57894-061, 57894-054) , ANALYSIS(57894-060, 57894-061, 57894-054)
ESTABLISHMENT
Name Address ID/FEI Business Operations
Janssen Biologics B.V.  409612918 ANALYSIS(57894-060, 57894-061, 57894-054) , API MANUFACTURE(57894-060, 57894-061, 57894-054)
ESTABLISHMENT
Name Address ID/FEI Business Operations
Baxter Pharmaceutical Solutions  604719430 MANUFACTURE(57894-060, 57894-061)
ESTABLISHMENT
Name Address ID/FEI Business Operations
Janssen Sciences Ireland UC  986030167 API MANUFACTURE(57894-060, 57894-061, 57894-054) , ANALYSIS(57894-060, 57894-061, 57894-054)
ESTABLISHMENT
Name Address ID/FEI Business Operations
PPD Development Ireland Ltd.  985036175 ANALYSIS(57894-054) 

以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 26 27 28 29 下一页 尾页 29/29/29
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇GENVOYA(elvitegravir, cobicista.. 下一篇RUBRACA™(rucaparib)tablets

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位